Padmanabh P. Bhatt - 01 Aug 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Sr. VP of IP, CSO
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
01 Aug 2024
Net transactions value
$0
Form type
4
Filing time
14 Aug 2024, 17:00:09 UTC
Previous filing
25 Mar 2024
Next filing
20 Aug 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Padmanabh P. Bhatt filed Form 4 for SUPERNUS PHARMACEUTICALS, INC. (SUPN) on 14 Aug 2024."

Quick Takeaways

  • This page summarizes Padmanabh P. Bhatt's Form 4 filing for SUPERNUS PHARMACEUTICALS, INC. (SUPN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 14 Aug 2024, 17:00.

What Changed

  • Previous filing in this sequence was filed on 25 Mar 2024.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 9,001 01 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Award $0 +1,250 $0.000000 1,250 01 Aug 2024 Common Stock 1,250 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 431 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2 On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.

Sponsored